Jacques Galipeau, MD, FRCP, PACT Director, recently presented at the Department of Neurosurgery Grand Rounds. The full presentation, “Mesenchymal Stromal Cells for TBI – A first-in-human clinical trial proposal,” can be viewed below:
Year: 2021
PACT MANUFACTURING SPECIALIST EARNS CPGP CERTIFICATION
Olga Ganz, one of PACT’s two cell manufacturing specialists, has recently completed the necessary qualifications for the American Society for Quality, Certified Pharmaceutical GMP Professional (CPGP). A CPGP understands the good manufacturing practices (GMP) as …
KIM MCDOWELL PROMOTED TO DIRECTOR OF REGULATORY AFFAIRS FOR PROGRAM FOR ADVANCED CELL THERAPY
Kimberly McDowell, MD, PhD, has been named Director of Regulatory Affairs for the UW Program for Advanced Cell Therapy (PACT). McDowell has served as the program’s associate director of regulatory affairs since 2019, and has …
UW BEGINS NEW CLINICAL TRIAL TO TREAT FATAL BLOOD DISEASES IN CHILDREN, YOUNG ADULTS
The trial is being sponsored by the UW Program for Advanced Cell Therapy (PACT) in partnership with the Department of Pediatrics, Division of Pediatric Hematology, Oncology and Bone Marrow Transplant. The Food and Drug Administration-approved …
Galipeau Chats with UWCCC Emerging Leadership Board
In December 2020, PACT Director Jacques Galipeau took part in Emerging Leadership Board at UW Carbone Cancer Center’s Five Minutes at Five Q&A session about his work in the PACT Program. To view the interview, …